Drug Type Gene therapy |
Synonyms AMT 126, AMT126 |
Target |
Action modulators |
Mechanism S100A1 modulators(S100 calcium binding protein A1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Preclinical | United States | 08 Jan 2018 | |
| Heart Failure | Preclinical | Netherlands | 08 Jan 2018 |





